A new license deal for Specialised Therapeutics Asia wth the company acquiring rights to a new breast cancer medicine shown to reduce the risk of recurrence. …
New Stories
-
AbbVie: Not yet on Venclexta but future is positive
April 23, 2018 - - Latest News -
A proud industry committed to doing the right thing
April 23, 2018 - - Latest News -
March PBAC outcomes
April 23, 2018 - - Latest News -
GBMA confirms biosimilar education grant
April 23, 2018 - - Latest News -
Mayne officially opens US facility
April 20, 2018 - - Latest News -
The question is how and why now?
April 20, 2018 - - Latest News -
New report show rebates average 44% in New Zealand
April 20, 2018 - - Latest News